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Abstract
Objective:  To  establish  the  prevalence  of  sensorineural  hearing  loss  (SNHL),  as  well  as  the
predisposing  risk  factors,  in  children  and  adolescents  with  type  1  diabetes  mellitus  (T1DM)
attending the  Service  of  Endocrino-Pediatrics  and  Otolaryngology  Department  of  the  ‘‘Dr.  José
Eleuterio González’’  University  Hospital  and  the  Materno-Infantil  Hospital,  from  January  2011
to December  2012.
Material  and  methods: A  total  of  84  children  with  T1DM,  with  ages  between  6  and  18  years  old,
were studied.  Values  of  glycated  hemoglobin  (HbA1c)  were  assessed  and  Tonal  audiometry  and
Speech audiometry  tests  were  performed.
Results:  A  total  of  84  patients  with  a  diagnosis  of  T1DM  were  studied,  out  of  which  12  (14.3%)
presented  SNHL.  Fifty  percent  of  patients  with  hearing  loss  were  in  the  age  range  of  10--13
years old.  Regarding  time  of  evolution  with  the  disease  (T1DM),  33%  of  patients  with  more  than
5 years  with  T1DM  presented  SNHL,  and  nearly  88.9%  of  the  patients  with  less  than  5  years
with T1DM  presented  normal  hearing  (p  =  0.011).  Moreover,  65.47%  of  the  patients  presented
complications  due  to  poor  glycemic  control  at  some  point  in  the  evolution  of  their  disease.  All
(100%) diabetic  patients  with  SNHL  and  91%  of  the  patients  without  SNHL  had  HbA1c  values
greater than  6%.  In  patients  with  hearing  impairments,  83.3%  suffered  mild  and  16.4%  suffered
moderate  hearing  loss.  Most  presented  bilateral  hearing  loss,  with  the  right  ear  dominating.
Acute frequencies,  mainly  8000  kHz,  were  the  most  affected.∗ Corresponding author at: Servicio de Otorrinolaringología del Hospital Universitario ‘‘Dr. José Eleuterio González’’ de la Universidad
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:Conclusion:  SNHL  prevalence  among  our  diabetic  population  was  14.3%,  which  indicates  that  a
sixth of  our  diabetic  type  1  population  will  develop  SNHL.  According  to  the  results  obtained,
SNHL is  more  frequent  among  patients  who  have  had  T1DM  for  more  than  5  years.  Nevertheless,
more studies  are  required  to  conﬁrm  that  there  is  a  relation  between  time  spent  with  the  disease
and SNHL.
©  2015  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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84  patients  were  divided  into  3  groups  based  on  age:  6--9,
10--13,  and  14--18  years  old.  We  observed  that  72  patients
with  a T1DM  diagnosis  showed  normal  hearing  while  12  T1DM
patients  showed  sensorineural  hearing  loss  (Fig.  1).
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he  World  Health  Organization  (WHO)  deﬁnes  diabetes
ellitus  (DM)  as  a  multiple-etiology  metabolic  disorder,
haracterized  by  chronic  hyperglycemia  and  other  metabolic
bnormalities,  which  result  in  absolute  or  relative  insulin
eﬁciency.  It  is  the  most  frequent  endocrine-metabolic  dis-
rder  in  children  and  adolescents,  and  has  remained  the
ain  type  of  diabetes  in  children.1--4
Type  1  diabetes  mellitus  (T1DM)  is  a  disease  with  an  eti-
logy  of  intervening  environmental  factors  which  interact
ith  a  genetic-predisposition  component;  it  is  considered  a
hronic  autoimmune  disease  which  causes  the  destruction
f  the  pancreatic    cells  which  produce  insulin.5
The  average  age  of  the  onset  of  the  disease  is  between  7
nd  15  years  of  age;  however,  it  may  occur  at  any  age.6
alues  of  the  HbA1c  >  6%  higher  than  the  normal  range
5--6%)  have  been  considered  a  risk  of  developing  micro-  and
acroangiopatic  complications.  The  affection  of  the  blood
essels  which  supply  the  inner  ear  and  the  vascular  stria  have
een  reported  by  different  authors  as  a  physiopathological
ause  of  SNHL  in  T1DM  patients.3,7 Treatment  with  insulin,
aintaining  on  average  HbA1c  of  7.2%,  reduces  the  onset
nd  progression  of  microangiopatic  complications,  atrophy,
nd  demyelination  of  the  spiral  ganglion  by  up  to  76%.8,9,13
Sensorineural  hearing  loss  (SNHL)  is  a  loss  of  hearing  at
ny  frequency  more  than  25  dB,  with  conductive  and  sen-
orineural  gaps  lower  that  20  dB,  and  affecting  the  patient’s
bility  to  communicate,  his  or  her  education,  job  prospects
nd  social  relationships,  and  also  causes  stigmatization.11,12
The  reported  prevalence  of  SNHL  is  up  to  33%  in  children
ith  T1DM  versus  0.3--0.5%  in  healthy  children.  In  Mexico
here  is  a  lack  of  sufﬁcient  epidemiologic  information  which
eﬁnes  the  hearing  condition  prevailing  in  our  population.12
aterials and methods
 prospective  longitudinal,  analytic,  comparative  study  was
onducted  on  a  total  of  87  patients  of  both  sexes,  ages
--18,  with  a  T1DM  diagnosis,  from  the  Service  of  Endocrino-
ediatrics  and  Otolaryngology  Department  of  the  ‘‘Dr.  José
leuterio  González’’  University  Hospital  and  the  Materno-
nfantil  Hospital,  from  January  2011  to  December  2012.
We  included  patients  who  agreed  to  participate  in  the
rotocol  through  a  signed  informed  consent,  signed  by  their
arents  and/or  guardians  and/or  the  patient.  We  excluded
atients  with  noise  exposure,  a  family  history  of  deafness,
se  of  ototoxic  medications,  otitis  media,  a  history  of
F
hrevious  ear  surgery  (except  ventilation  tube  insertion)  and
M  type  2.
All  subjects  in  this  study  were  given  a  questionnaire,
hich  included  family,  prenatal,  natal  and  personal  patho-
ogical  and  non-pathological  history.  Patients  underwent
asic  otorhinolaryngological  exploration,  tone  audiometry
nd  oral  audiometry  using  an  audiometer  AUDIOTEST  259b,
anufactured  for  Interacustics,  Type  2  Tone  Audiometer,
ype  B-E-T  speech  audiometer  in  a  soundproof  cabin  Acous-
ics  Systems,  Model  RE-142,  Serial  #21413a,  made  in  USA.
he  study  was  approved  by  the  Ethics  and  Research  Commit-
ee  of  the  School  of  Medicine  of  the  Universidad  Autónoma
e  Nuevo  León  (UANL  by  its  Spanish  acronym)  with  the  reg-
stration  key  OT12-002.
The  information  obtained  was  gathered  in  a  database
sing  Excel,  performing  statistical  analysis  using  SPSS  20.0.
e  obtained  the  traditional  statistics  in  the  quantitative
nd  qualitative  variables,  looking  to  establish  differences
etween  both  groups  through  hypothesis  tests  for  means  and
roportions,  to  establish  the  absence  or  presence  of  associa-
ion  and  correlation  using  chi  square,  Pearson  or  Spearman,
ith  a  conﬁdence  and  reliability  of  95%.
esults
ut  of  the  87  recruited  patients  with  a  T1DM  diagnosis,  we
xcluded  a  patient  with  a  history  of  chronic  otitis  media  of
he  right  ear,  one  with  otitis  media  with  bilateral  effusion
nd  a  patient  with  a  ﬁnal  diagnosis  of  T2DM.  The  remainingigure  1  Average  of  patients  with  type  1  diabetes  with  normal
earing and  sensorineural  hearing  loss.
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Figure  2  Comparison  of  both  groups  by  age  range.
The  6--9  group  included  20  patients  (9  girls  and  11  boys)
with  diabetes  with  an  evolution  time  of  less  than  5  years;  10
(50%)  subjects  presented  a  history  of  previous  complications
like  ketoacidosis,  hyperglycemia  or  hypoglycemia,  2  (10%)
patients  had  HbA1c  <  6  and  18  HbA1c  >  6,  and  1  (5%)  sub-
ject  presented  mild  SNHL  for  8000  kHz  thresholds.  The  10--13
group  included  a  total  of  30  patients  (13  girls  and  17  boys);
29  (34.5%)  had  had  diabetes  mellitus  for  less  than  5  years  and
1  (1.21%)  for  over  5  years,  18  (21.4%)  patients  presented  a
history  of  ketoacidosis,  hypo-  or  hyperglycemia,  29  (34.52%)
presented  HbA1c  >  6  and  1  (1.19%)  HbA1c  <  6;  mild  SNHL  was
displayed  in  3  (3.57%)  subjects  and  1  (1.19%)  patient  dis-
played  moderate  SNHL,  and  all  4  patients  were  in  hearing
thresholds  of  8000  kHz.  The  14--18  group  consisted  of  34
patients  (40.47%)  (20  girls  and  14  boys),  22  (64.70%)  with
an  evolution  time  of  less  than  5  years  and  12  (35.29%)  for
more  than  5 years;  complications  like  ketoacidosis,  hypo-
or  hyperglycemia  were  reported  by  27  of  them;  3  (8.82%)
subjects  showed  an  HbA1c  <  6  and  31  (91.17%)  an  HbA1c  >  6;
SNHL  occurred  within  this  group  in  7  individuals  (mild  in  6
and  moderate  in  1).  In  all  patients,  SNHL  was  observed  in
thresholds  of  8000  kHz  (See  Table  1).
In  our  study,  we  were  able  to  observe  a  percentage  preva-
lence  of  SNHL  of  14.3%  (12  out  of  84  patients).  Also,  64
patients  (76.19%)  with  T1DM  were  older  than  10  years  of
age,  as  opposed  to  a  small  group  of  20  patients  (23.80%)
between  the  ages  of  6  and  9  (Fig.  2).  There  were  no  differ-
ences  in  gender,  each  representing  50%.  In  regard  to  time  of
evolution  of  T1DM,  15.47%  (13  patients)  with  over  5  years
with  T1DM  presented  SNHL,  and  84.52%  (71  patients)  with
less  than  5  years  with  T1DM  presented  normal  hearing,  this
being  a  statistically  signiﬁcant  value  (p  =  0.011)  (Fig.  3).
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Figure  3  Comparison  of  both  groups  by  T1DM  evolution  time.
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Out  of  the  84  patients,  55  (64.47%)  presented
omplications  at  some  point  during  the  evolution  of  their
isease  due  to  glycemic  irregularities;  the  most  frequent
omplication  was  ketoacidosis  and  the  least  prevalent  was
ypoglycemia  (Fig.  4).
In  the  present  study,  100%  of  diabetic  patients  with  SNHL
12  patients)  and  91%  of  patients  with  normal  hearing  pre-
ented  HbA1c  values  greater  than  6%,  showing  an  average
alue  of  7.5%  in  the  general  population  studied.  Accord-
ng  to  age  groups,  the  group  consisting  of  children  between
 and  12  years  presented,  on  average,  an  HbA1c  value  of
.24%,  while  the  group  consisting  of  children  between  13
nd  19  years  of  age  presented,  on  average,  an  HbA1c  value
f  7.67%.
Of  all  the  SNHL  patients,  83.30%  (10  patients)  presented
ild  hearing  loss  and  16.70%  (2  patients)  moderate  hear-
ng  loss  (Fig.  5).  Most  patients  presented  bilateral  hearing
oss,  predominately  on  the  right  ear.  The  8000  kHz  thresholds
ere  the  most  affected.  (Table  1)
iscussion
n  SNHL  prevalence  of  up  to  33%  in  children  with  T1DM
as  been  considered,  versus  0.3--0.5%  in  healthy  children.
n  Mexico,  there  is  a  lack  of  epidemiologic  information  that
an  deﬁne  the  hearing  condition  which  prevails  among  our
opulation.12
The  observed  prevalence  in  our  studied  group  was  14.3%,
ontrary  to  the  rate  reported  in  different  publications.
a
d
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owever,  we  must  keep  in  mind  that  most  of  the  studied
opulation  is  American  or  European.  It  is  important  to  stress
he  fact  that  there  are  still  many  T1DM  cases  that  have
ot  been  diagnosed,  but  with  the  obtained  results  at  this
oint,  we  are  able  to  infer  that  up  to  a  sixth  of  the  diabetic
opulation  in  our  society  will  develop  SNHL.
Regarding  age,  the  obtained  information  matches  the  one
ound  in  the  bibliography.  Most  children  are  in  the  mentioned
eak  ranges,  especially  above  10  years  of  age,  beginning
ith  hormone  changes  that  are  a  normal  part  of  puberty  and
dolescence.  Nevertheless,  based  on  the  obtained  results
e  are  able  to  see  that  the  patient’s  age  does  not  represent
 risk  factor  for  the  presence  of  SNHL.
According  to  the  American  Diabetes  Association  (ADA)
nd  the  Diabetes  medical  attention  standards  of  2014,  the
oal  for  HbA1c  in  type  1  diabetic  patients  varies  depend-
ng  on  age.  Concerning  values  <8%  in  the  6--12  years-of-age
ange,  because  it  is  not  possible  to  have  more  strict  goals
ue  to  the  risk  of  developing  hypoglycemia,  even  in  this
ge  range  we  can  demand  goals  of  <7.5%  in  speciﬁc  cases
here  patients  do  not  present  severe  hypoglycemia.  In  the
3--19  years-of-age  range,  values  of  <7.5%  are  considered
nd  in  speciﬁc  cases  even  <7%.  In  children  under  6  years  of
ge,  goals  of  <8%  are  too  strict,  so  up  to  <8.5%  is  accept-
ble,  because  these  children  have  a  greater  vulnerability
or  hypoglycemia,  a greater  sensitivity  to  insulin,  and  are
npredictable  in  their  intake  and  physical  activity.10
The  average  population  showed  HbA1c  values  of  7.5%  and
aking  the  results  by  age  group  into  account,  we  are  able  to
ay  that  our  patients,  under  13  years  of  age  with  an  HbA1c
verage  of  7.24%,  are  within  an  adequate  glycemic  control,
ecause  they  are  inside  the  accepted  range  by  the  ADA  2014
6--12  years  =  <8%);  and  patients  older  than  13  years  of  age
ith  an  average  of  7.67%  show  a  control  barely  above  that
xpected  for  their  age  group  (13--19  years  =  <7.5%).
It  is  important  to  maintain  HbA1c  values  as  close  to
ormal  as  possible,  thus  reducing  by  almost  80%  the  risk
f  presenting  microangiopatic  complications;  however,  we
ust  not  be  very  strict  with  our  population,  especially  with
hildren  under  13  years  of  age,  because  of  the  risks  of  pre-
enting  severe  or  belated  hypoglycemia  cases,  and  hence
he  importance  of  following  the  standards  established  by
he  ADA  2014.
Regarding  time  of  evolution  with  T1DM,  it  was  the  only
tatistically  signiﬁcant  risk  factor  (p  =  0.011)  for  a  period
reater  than  5  years  and  the  presence  of  hearing  loss.  How-
ver,  when  we  looked  for  the  correlation  between  both
actors,  we  did  not  ﬁnd  it.  The  present  study  showed  a
reater  prevalence  of  hearing  loss  in  patients  with  more
han  5  years  of  evolution  of  T1DM,  without  it  being  asso-
iated  or  related.  This  could  be  due  to  the  lack  of  potency
n  the  studied  population  who  presented  T1DM  and  SNHL,
equiring  a  greater  number  of  patients  and  further  research.
evertheless,  it  is  important  that  5  years  after  a  T1DM  diag-
osis,  as  there  is  an  already  established  protocol  in  search  of
icroangiopatic  complications  like  retinopathy,  we  estab-
ish  the  application  of  hearing  studies  which  allow  us  to
etect  hearing  problems  in  a  timely  manner.Out  of  all  of  our  patients  with  SNHL,  83.3%  presented
 mild  hearing  loss,  bilaterally,  in  acute  frequencies,  pre-
ominately  8000  Hz,  which  agrees  with  the  rate  obtained
n  previous  studies.  The  type  of  hearing  loss  presented
11
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in  these  patients  is  similar  to  the  one  that  patients  with
presbycusis  would  present,  but  at  an  earlier  age  compared
to  the  population  without  T1DM.
This  research  provided  valuable  data  to  lead  the  way
for  new  researches  in  these  types  of  patients,  and  estab-
lish  a  timely  and  protocol-led  assessment  for  their  glycemic
control  as  well  as  their  hearing,  thus  avoiding  hearing
complications  which  patients  with  a  T1DM  of  long  duration
present,  like  SNHL  and  sudden  hearing  loss.  Also,  later  stud-
ies  are  recommended  where  a  long-term  follow-up  is  given
to  these  patients  in  order  to  determine  the  causation  degree
of  the  studied  risk  factors  on  the  base  pathology.
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